Accessibility Statement

Publications | July 11, 2019

IPR For Biosimilars: Examining The Benefits And Drawbacks

Biosimilar Development

Author

John L. Abramic

Overview

Steptoe partner John Abramic authored an article titled "IPR For Biosimilars: Examining The Benefits And Drawbacks" for Biosimilar Development. The article, published July 11, examines the use of inter partes review (IPR) proceedings for matters involving biosimilars.

Professionals

John L. Abramic
John Abramic is chair of Steptoe’s Intellectual Property group and the former managing partner of the Chicago office. He is a veteran advocate in complex intellectual property disputes and has served...

Partner

Patent Litigation, Post-Grant Proceedings, Trade Secrets, Patent

Practices

Patent Litigation

Patent

Press Releases International Arbitration Attorney Robert Reyes Landicho Joins Steptoe’s International Disputes Practice in Houston March 30, 2026 Press Releases Steptoe Recognized With Two Honors in GCR Awards 2026 March 27, 2026 Webinars AI, Data & Digital Roundtable on the Insurance of AI Risk April 8, 2026
Press Releases Veteran Financial Regulatory Litigator Trace Schmeltz Joins Steptoe's Investigations, White-Collar Defense & Compliance Group March 23, 2026 Press Releases Chambers Europe 2026 Recognizes Steptoe Practices and Lawyers March 19, 2026 Press Releases Steptoe Recognized for Exceptional Cross‑Border Litigation Work in China Business Law Journal’s Deals of the Year 2025 March 13, 2026 Global Trade & Investment Law Blog US Supreme Court Strikes Down IEEPA Tariffs February 20, 2026 Press Releases Steptoe Earns "Highly Recommended" Recognition in World IP Review's USA Patent Rankings 2025 February 18, 2026 Press Releases Steptoe Attorneys Michael Allan and Joseph Ecker Recognized in 2026 WTR 1000 February 18, 2026 Press Releases Steptoe Expands Energy Regulatory and Pipeline Reach with Amy Hoff Joining as Houston Partner February 13, 2026 Press Releases Steptoe Highly Ranked in Chambers Global 2026 February 13, 2026 Press Releases Steptoe Expands Trade Remedies Group With Addition of Partner Ron Kendler February 2, 2026

View More